Abbott Laboratories (ABT)
NYSE: ABT · Real-Time Price · USD
94.12
+0.88 (0.94%)
At close: Jun 26, 2026, 4:00 PM EDT
93.90
-0.22 (-0.23%)
After-hours: Jun 26, 2026, 7:58 PM EDT

Abbott Laboratories Stock Forecast

Stock Price Forecast

According to 27 analysts polled by S&P Global, Abbott Laboratories stock has a consensus rating of "Buy" and an average price target of $116.54. The average 1-year stock price forecast is 23.82% higher than the current stock price, while the lowest is $92 (-2.25%) and the highest is $135 (+43.43%).

Price Target: $116.54 (+23.82%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$92$116.54$115$135
Change-2.25%+23.82%+22.18%+43.43%

Analyst Ratings

The average analyst rating for Abbott Laboratories stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingJan '26Feb '26Mar '26Apr '26May '26Jun '26
Strong Buy151616161616
Buy666544
Hold777777
Sell000000
Strong Sell000000
Total282929282727

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Piper Sandler
Piper Sandler
Buy
Reiterates
$115
BuyReiterates$115+22.18%Jun 22, 2026
Citi
Citi
Buy
Maintains
$108$89
BuyMaintains$108$89-5.44%Jun 17, 2026
Wells Fargo
Wells Fargo
Buy
Maintains
$109
BuyMaintains$109+15.81%Jun 15, 2026
Bank of America Securities
Bank of America Securities
Buy
Reiterates
$120$102
BuyReiterates$120$102+8.37%Jun 11, 2026
TD Cowen
TD Cowen
Buy
Maintains
n/a
BuyMaintainsn/an/aJun 10, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
50.29B
from 44.33B
Increased by 13.45%
Revenue Next Year
54.79B
from 50.29B
Increased by 8.95%
EPS This Year
5.48
from 5.15
Increased by 6.47%
EPS Next Year
6.06
from 5.48
Increased by 10.50%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
43.08B43.65B40.11B41.95B44.33B50.29B
Revenue Growth
24.47%1.34%-8.12%4.59%5.67%13.45%
Gross Profit
25.00B24.57B22.19B23.31B25.12B28.98B
Gross Margin
58.03%56.28%55.32%55.56%56.66%57.62%
Operating Income
9.20B9.11B7.22B7.50B8.92B11.66B
Net Income
7.07B6.93B5.72B13.40B6.52B7.02B
EPS
----5.155.48
EPS Growth
----10.28%6.47%
Forward PE
30.0526.6424.2222.3922.6317.17
Dividend / Share
1.821.922.082.242.402.55
Dividend Growth
-5.49%8.33%7.69%7.14%6.11%
Free Cash Flow
7.68B7.34B4.99B5.61B6.29B8.63B
No. Analysts
-----24
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High50.6B
Avg50.3B
Low47.8B

Revenue Growth

Revenue Growth202620272028
High
14.1%
Avg
13.4%
Low
7.9%

EPS Forecast

EPS202620272028
High5.71
Avg5.48
Low5.40

EPS Growth

EPS Growth202620272028
High
10.9%
Avg
6.5%
Low
4.9%